← All roles

Scientist (Immunology), Vienna

Apply on company site
Vienna€60kFull-timePosted 4w ago

About the role

Immunology-focused scientist role at Parallel Bio in Vienna, developing immune organoid models and advancing disease modelling for human-first drug discovery.

Responsibilities

  • Design, execute and interpret immune organoid experiments in tissue culture, working with primary human cells and stem cell-derived models.
  • Establish, optimize and troubleshoot assays for immune activation, cell phenotyping and functional response.
  • Connect bench observations to drug development decisions and design experiments accordingly.
  • Tackle open-ended work with trial-and-error approaches; set project direction and priorities; manage multiple projects concurrently.
  • Work with computational and automation teams to ensure biological interpretation guides platform development; utilize lab automation; write and implement SOPs for site transfers.
  • Produce clear experimental documentation and contribute to reports and presentations.
  • Mentor junior scientists and share knowledge; present findings in internal meetings; flag data limitations and ambiguous results.

Qualifications

  • PhD in immunology, cell biology or closely related life sciences discipline.
  • 5+ years of experience in biotech, pharma or translational research contexts.

Skills

Required:Immunology
Last updated Sep 30, 2026. Interested? Apply on the company site.
Parallel Bio logo

About Parallel Bio

Using the immune system to cure disease

Parallel Bio created a human 'immune system in a dish' to discover drugs and immunotherapies more likely to work in patients. Our platform has all of the same elements as a human immune system, meaning you can test drugs and vaccines as if you were testing them in actual patients from the start. The biggest reason why 95% of new drugs fail is that they were tested in mice - but with our human platform, pharma companies will know which drugs will successfully treat patients, speeding up the process and reducing the cost. To date our platform has successfully been used to test 12 drugs, and vaccines against 8 different diseases. The company is founded by Robert DiFazio, a former Stanford R&D director with a PhD in immunology, and Juliana Hilliard, a former System1 Biosciences R&D lead with an MSc in bioengineering, both of whom have led drug discovery programs for years.

ai-powered-drug-discoverybiotech

More open roles at Parallel Bio